BIIB 131.57 -0.09 / Biogen Idec, Inc. BIIB 131.57 -0.09 / Biogen Idec, Inc. | Benzinga

Friday, May 18, 2012

Disney, Raytheon and Other Avenger Picks for a Heroic Portfolio (BDSI, BIIB, DIS, GD, GV, IYC, Long Ideas, MUSA, PATK, PEJ, RTN, THO, TWX, VCR, X, XBI, XHB, XLK, XLY, Short Ideas, Trading Ideas, ETFs / Fri, 06:40am)

Wednesday, May 09, 2012

Biogen Idec Announces US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review (BIIB, News, FDA / Wed, 04:08pm)

Wednesday, May 02, 2012

UPDATE: Jefferies Raises PT to $154 on Biogen Idec; Strong MS Dynamics (Analyst Color, BIIB, Price Target, Reiteration, Pre-Market Outlook, Analyst Ratings / Wed, 07:52am)

Tuesday, May 01, 2012

Financial Breakfast: Morning News Summary for May 1, 2012 (ADM, AZN, BIIB, Bonds, COST, CYH, Earnings, HRS, IPSU, News, PAY, PFE, Futures, Upgrades, Commodities, Downgrades, Forex, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Tue, 07:29am)

Tuesday, April 24, 2012

Biogen Idec Announces Positive Results from Phase 3 CONFIRM Clinical Trial Show Efficacy and Safety of Oral BG-12 in Multiple Sclerosis (BIIB, News, FDA / Tue, 07:33am)

Wednesday, April 04, 2012

Benzinga's Top Upgrades (AKAM, BIIB, CIEN, GPS, Upgrades, Analyst Ratings / Wed, 08:01am)
UPDATE: Goldman Sachs Upgrades Biogen Idec; Raises PT (Analyst Color, BIIB, Upgrades, Price Target, Analyst Ratings / Wed, 07:38am)
Financial Breakfast: Morning News Summary for April 4, 2012 (BIIB, Bonds, DDIC, MCD, MDCA, News, SBUX, THI, VIAS, Futures, Guidance, Upgrades, Downgrades, Forex, Technicals, FDA, M&A, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Wed, 07:24am)

Thursday, March 15, 2012

UPDATE: Stifel Nicolaus Resumes Buy, $144 PT on Biogen Idec (Analyst Color, BIIB, Price Target, Initiation, Intraday Update, Analyst Ratings / Thu, 11:35am)

Wednesday, March 14, 2012

Biogen Idec Takes Option to MAKScientific MS Program (BIIB, News, FDA / Wed, 10:19am)

Thursday, March 08, 2012

Biogen Idec Spokesperson Refutes Claims of Biopharm Insight Article (BIIB, News, Rumors, FDA, Movers, General / Thu, 03:24pm)

Tuesday, February 28, 2012

Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis (BIIB, News, FDA / Tue, 09:02am)
A Peek Into The Market Before The Trading Starts (AMAP, BIIB, FWLT, News, NOK, RRD, Futures, Global, Pre-Market Outlook, Markets / Tue, 08:48am)
Biogen Idec Announces FDA Approves AVONEX PEN and Dose Titration Regimen (BIIB, News, FDA / Tue, 08:33am)
Samsung Biologics and Biogen Idec Announce Formation of Biosimilars Joint Venture Samsung Bioepis (BIIB, News, Contracts, FDA / Tue, 08:17am)

Tuesday, February 14, 2012

Benzinga's M&A Chatter for Tuesday February 14, 2012 (BIIB, BMY, CVI, HIG, INTC, Long Ideas, MDAS, News, VRTX, Short Ideas, Rumors, M&A, Global, After-Hours Center, Trading Ideas / Tue, 07:32pm)
Biogen Idec to Acquire Stromedix (BIIB, News, M&A / Tue, 09:31am)

Friday, February 10, 2012

Morgan Stanley Initiates Coverage on Biogen Idec at Overweight, Announces PT of $140 (BIIB, Price Target, Initiation, Analyst Ratings / Fri, 07:39am)

Tuesday, January 31, 2012

Benzinga's Top Pre-Market Losers (ADM, BIIB, News, REXX, S, Movers & Shakers, Pre-Market Outlook, Markets / Tue, 09:24am)

Thursday, January 26, 2012

From Earlier: Biogen Idec and Elan Corporation Announce ASCEND Study to Evaluate the Effectiveness of TYSABRI as a Treatment for Secondary-Progressive Multiple Sclerosis (BIIB, ELN, MS, News, RRMS, FDA / Thu, 09:53am)

Monday, January 23, 2012

Oppenheimer Releases Biogen Idec Company Update (Analyst Color, BIIB, Reiteration, Analyst Ratings / Mon, 10:43am)

Friday, January 20, 2012

Quest Diagnostics STRATIFY JCV First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients (BIIB, DGX, ELN, News, FDA / Fri, 05:00pm)
Deutsche Bank Maintains Buy on Biogen Idec After European Medical Agency Announcement (Analyst Color, BIIB, News, Reiteration, FDA, Global, Pre-Market Outlook, Analyst Ratings / Fri, 08:11am)

Wednesday, January 11, 2012

Citigroup Maintains Neutral on Biogen Idec After Analyst Meeting (Analyst Color, BIIB, News, Reiteration, Events, Intraday Update, Analyst Ratings / Wed, 03:12pm)

Monday, January 09, 2012

Just What The Doctor Ordered: 4 ETFs For Biotech M&A (ACHN, AFFX, ALXN, AMGN, BBH, BIIB, BMRN, BMY, CELG, DNDN, FBT, GILD, IDIX, INHX, ITMN, Long Ideas, News, PSCH, REGN, Sector ETFs, XBI, Short Ideas, Specialty ETFs, New ETFs, Rumors, Small Cap Analysis, Technicals, FDA, M&A, Events, Intraday Update, After-Hours Center, Markets, Movers, Trading Ideas, ETFs / Mon, 04:49pm)

Wednesday, January 04, 2012

Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Spinal Muscular Atrophy (BIIB, ISIS, News, SMA, FDA / Wed, 09:31am)

Thursday, December 29, 2011

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Highest Operating Margin (AMGN, BIIB, CELG, GILD, Trading Ideas / Thu, 04:21am)

Tuesday, December 27, 2011

Best Biotech Stocks of 2011 (ACHN, AMGN, ARIA, BIIB, DNDN, GILD, IDIX, IMGN, INHX, JAZZ, JNJ, LLY, Long Ideas, MDVN, NVS, OPTR, PFE, SGEN, SPPI, VPHM, VRTX, VRUS, Short Ideas, Trading Ideas / Tue, 11:39am)

Tuesday, December 20, 2011

Deutsche Bank Reiterates Buy, $129 PT On Biogen Idec (Analyst Color, BIIB, News, Price Target, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Tue, 12:18pm)

Tuesday, December 06, 2011

J.P. Morgan Reiterates Neutral On Biogen Idec (Analyst Color, BIIB, News, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Tue, 02:28pm)

Monday, December 05, 2011

ISI Reiterates Buy, $120 PT On Biogen (Analyst Color, BIIB, ISI, News, Price Target, Reiteration, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Mon, 02:18pm)

Friday, December 02, 2011

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Highest EPS (ALXN, AMGN, BIIB, CELG, Trading Ideas / Fri, 10:37am)

Tuesday, November 22, 2011

Idenix and Spectrum Pharmaceuticals to Open Near 52-Week Highs (BIIB, GILD, IDIX, Long Ideas, SPPI, VRUS, Short Ideas, Pre-Market Outlook, Trading Ideas / Tue, 07:49am)

Monday, November 14, 2011

Deutsche Bank Maintains Buy Rating and $129 PT on Biogen Idec (Analyst Color, BIIB, Reiteration, Analyst Ratings / Mon, 08:44am)
JP Morgan Maintains Neutral for Biogen Idec on Positive Lemtrada Data (Analyst Color, BIIB, Reiteration, Analyst Ratings / Mon, 08:43am)

Friday, October 28, 2011

Biogen IDEC Inc's Profit Up (BIIB, Earnings, News, After-Hours Center / Fri, 09:27am)